Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.18
+0.24 (2.01%)
At close: Dec 5, 2025, 4:00 PM EST
11.94
-0.24 (-1.97%)
After-hours: Dec 5, 2025, 7:51 PM EST
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$353,610
Profits / Employee
$711
Market Cap
3.83B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMRX News
- 17 hours ago - Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson's Disease - GlobeNewsWire
- 3 days ago - Amneal to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 days ago - Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol - GlobeNewsWire
- 4 days ago - Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% - GlobeNewsWire
- 7 days ago - Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares? - The Motley Fool
- 14 days ago - Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs - The Motley Fool
- 22 days ago - Amneal Receives U.S. FDA Approval for Iohexol Injection - GlobeNewsWire
- 5 weeks ago - Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call Transcript - Seeking Alpha